Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Feb 2022 07:00 AM
RNS
Update to agreement with Sio Gene Therapies
31 Jan 2022 09:13 PM
Oxford Biomedica announces update to agreement ...
31 Jan 2022 11:21 AM
RNS
Market Share Purchase
28 Jan 2022 05:59 PM
RNS
Result of Placing and PrimaryBid offer
28 Jan 2022 02:04 PM
RNS
Holdings in Company
28 Jan 2022 07:39 AM
Oxford Biomedica broadens leading viral vector ...
28 Jan 2022 07:38 AM
RNS
Retail offer by PrimaryBid
28 Jan 2022 07:24 AM
RNS
US Agreement and Proposed Placing of Shares
17 Jan 2022 07:00 AM
RNS
John Dawson to retire from Oxford Biomedica
05 Jan 2022 07:00 AM
RNS
Oxford Biomedica Agreement with Cabaletta Bio
04 Jan 2022 11:07 AM
RNS
Block listing Return
04 Jan 2022 10:32 AM
RNS
Total Voting Rights
04 Jan 2022 07:00 AM
RNS
John Dawson awarded CBE in New Year Honours List
14 Dec 2021 07:00 AM
RNS
Board Appointment
13 Dec 2021 07:00 AM
RNS
Oxford Biomedica Updates Lentiviral Agreement
13 Dec 2021 07:00 AM
RNS
Oxford Biomedica Signs Agreement with Arcellx
01 Dec 2021 09:49 AM
RNS
Total Voting Rights
01 Nov 2021 10:08 AM
RNS
Long Term Incentive Plan Option Grant
01 Nov 2021 10:02 AM
RNS
Total Voting Rights
19 Oct 2021 07:00 AM
RNS
Boehringer Ingelheim Exercises Option
01 Oct 2021 09:51 AM
RNS
Total Voting Rights
29 Sep 2021 05:54 PM
RNS
Holding(s) in Company
29 Sep 2021 05:36 PM
RNS
Directors Dealings / Market Share Purchases
28 Sep 2021 04:48 PM
RNS
Holding(s) in Company
28 Sep 2021 10:01 AM
RNS
Total Voting Rights
22 Sep 2021 07:38 AM
RNS
Strategic investment by Serum Life Sciences
22 Sep 2021 07:00 AM
RNS
Interim Results
01 Sep 2021 10:48 AM
RNS
Total Voting Rights
01 Sep 2021 07:00 AM
RNS
Notice of Interim Results
03 Aug 2021 02:20 PM
RNS
LTIP Option Grant
02 Aug 2021 11:16 AM
RNS
Total Voting Rights
15 Jul 2021 07:00 AM
RNS
Non-Executive Director Appointment
06 Jul 2021 03:10 PM
RNS
Director/PDMR Shareholding
01 Jul 2021 11:35 AM
RNS
Block listing Return
01 Jul 2021 10:43 AM
RNS
Total Voting Rights
24 Jun 2021 01:05 PM
RNS
Directors Dealings / Market Share Purchases
09 Jun 2021 10:36 AM
RNS
Holding(s) in Company
08 Jun 2021 02:32 PM
RNS
Grant of options
01 Jun 2021 10:13 AM
RNS
Total Voting Rights
28 May 2021 07:00 AM
EQS
Oxford Biomedica (OXB): Driving innovation in a...
28 May 2021 07:00 AM
RNS
Block Listing Application
28 May 2021 07:00 AM
RNS
Result of AGM
27 May 2021 07:00 AM
RNS
Board Change
25 May 2021 09:21 AM
RNS
Director/PDMR Shareholding
21 May 2021 12:46 PM
RNS
PDMR Dealing
20 May 2021 11:42 AM
RNS
PDMR Dealings
18 May 2021 07:00 AM
RNS
Oxford Biomedica upgrades financial guidance
18 May 2021 07:00 AM
Oxford Biomedica upgrades financial guidance fo...
10 May 2021 10:54 AM
RNS
Holding(s) in Company
04 May 2021 10:29 AM
RNS
Total Voting Rights

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100